Clay Thorp Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Clay Thorp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clay Thorp. Clay Thorp is a Director in PhaseBio Pharmaceuticals Inc ($PHAS) and a Director in Clearside Biomedical, Inc. ($CLSD) and a 10% Owner in G1 Therapeutics, Inc. ($GTHX).
Address: C/O HATTERAS VENTURES 280 S. MANGUM ST., SUITE 350 DURHAM 27701 NC
Companies in which Clay Thorp is an Insider
Clearside Biomedical, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clay Thorp: Director
Holdings: 3,433,521 shares
Current Value: $24,893,027
Latest Transaction: Feb 12 2021
$CLSD Market Capitalization: $146.03M
$CLSD Previous Close: $7.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
G1 Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clay Thorp: 10% Owner
Holdings: 3,279,421 shares
Latest Transaction: Jun 01 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PhaseBio Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clay Thorp: Director
Holdings: 1,818,638 shares
Latest Transaction: Jun 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Clay Thorp
Sentiment: All, CLSD, GTHX, PHAS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | A | 3.53 | 14,000 | 49,420 | 14,000 | |
| Feb 12 2021 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Sell | S | 4.43 | 32,873 | 145,627 | 3,433,521 | 3.5 M to 3.4 M (-0.95 %) |
| Jun 19 2020 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
| Jun 05 2020 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Option Exercise | A | 4.86 | 16,000 | 77,760 | 16,000 | |
| Nov 26 2019 | CLSD | Clearside Biomedic ... | Thorp Clay | Director | Grant | A | 1.05 | 1,518,026 | 1,599,999 | 4,984,420 | 3.5 M to 5 M (+43.79 %) |
| Jul 03 2019 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Sell | S | 14.00 | 459 | 6,426 | 415,959 | 416.4 K to 416 K (-0.11 %) |
| Jul 03 2019 | PHAS | PhaseBio Pharmaceu ... | Thorp Clay | Director | Sell | S | 14.00 | 255 | 3,570 | 52,397 | 52.7 K to 52.4 K (-0.48 %) |